Comparision of vacuum-asisted closure and moist wound dressing in the treatment of diabetic foot ulcers

Hassan Ravari, Mohammad-Hadi Saeed Modaghegh, Gholam Hosein Kazemzadeh, Hamed Ghoddusi Johari, Attieh Mohammadzadeh Vatanchi, Abolghasem Sangaki, Mohammad Vahedian Shahrodi, Hassan Ravari, Mohammad-Hadi Saeed Modaghegh, Gholam Hosein Kazemzadeh, Hamed Ghoddusi Johari, Attieh Mohammadzadeh Vatanchi, Abolghasem Sangaki, Mohammad Vahedian Shahrodi

Abstract

Background: Vacuum-assisted closure (VAC) is a new method in wound care which speeds wound healing by causing vacuum, improving tissue perfusion and suctioning the exudates. This study aims to evaluate its efficacy in the treatment of diabetic foot ulcers.

Materials and methods: Thirteen patients with diabetic foot ulcers were enrolled in the moist dressing group, and 10 patients in the VAC group. The site, size and depth of the wound were inspected and recorded before and every three days during the study period. Patient satisfaction and formation of granulation tissue were also assessed.

Results: Improvement of the wound in the form of reducing the diameter and depth and increasing proliferation of granulation tissue was significant in most of the patients of the VAC group after two weeks. Satisfaction of patients in the VAC group was evaluated as excellent as no amputation was done in this group. Wagner score was reduced in both the study groups, although this decrement was not significant in the moist dressing group.

Conclusion: VAC appears to be as safe as and more efficacious than moist dressing for the treatment of diabetic foot ulcers.

Keywords: Diabetic foot ulcers; moist wound dressing; vacuum-assisted closure; wound therapy.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Depth of ulcer before and after the treatment (mm); values are expressed as mean
Figure 2
Figure 2
Size of ulcer before and after the treatment (cm2); values are expressed as mean

References

    1. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382–7.
    1. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.
    1. Brem H, Shehan P, Rosenberg HJ, Schnieder JS, Boulton AJ. Evidence-based protocol for diabetic foot ulcers. Plast Reconstr Surg. 2006;117:193S–209.
    1. Boulton AJ, Vileikyte L. The diabetic foot: The scope of the problem. J Fam Pract. 2000;49(11 Suppl):S3–8.
    1. Lavery LA, Armstrong DG, Wunderlich RP, Boulton AJ, Tredwell JL. Diabetic foot syndrome: Evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-hispanic whites from a diabetes disease management cohort. Diabetes Care. 2003;26:1435–8.
    1. Mulder G, Armstrong D, Seaman S. Standard, appropriate, and advanced care and medical-legal considerations: Part one-diabetic foot ulcerations. Wounds. 2003;15:92–106.
    1. Glenview, IL: Wound Ostomy and Continence Nurses Society; 2002. Guideline for Management of Wounds in Patients with Lower-Extremity Arterial Disease.
    1. Martson WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: Results of prospective randomized trial. Diabetes Care. 2003;26:1701–5.
    1. Veves A, Falanga V, Armstrong DA, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: A prospective randomized multicenter clinical trial. Diabetes Care. 2001;24:2001–295.
    1. Robson MC, Payne WG, Garner WL, Biundo J, Giacalone VF, Cooper DM, et al. Integrating the results of phase IV (postmarketing) clinical trial with four previous trials reinforces the position that regranex (becaplermin) gel 0.01% is an effective adjunct to the treatment of diabetic foot ulcers. J Appl Res. 2005;5:35–45.
    1. Mannari RJ, Payne WG, Ochs DE, Walusimbi M, Blue M, Robson MC. Successful treatment of recalcitrant, diabetic heel ulcers with topical becaplermin (rhPDGF-BB) gel. Wounds. 2002;14:116–21.
    1. Peters EJ, Lavery LA, Armstrong DG, Fleischli JG. Electric stimulation as an adjunct to heal diabetic foot ulcers: A randomized clinical trial. Arch Phys Med Rehabil. 2001;82:721–5.
    1. Mouës CM, van den Bemd GJ, Heule F, Hovius SE. Comparing conventional gauze therapy to vacuum-assisted closure wound therapy: A prospective randomised trial. J Plast Reconstr Aesthet Surg. 2007;60:672–81.
    1. Wanner MB, Schwarzl F, Strub B, Zaech GA, Pierer G. Vacuum-assisted wound closure for cheaper and more comfortable healing of pressure sores: A prospective study. Scand J Plast Reconstr Surg Hand Surg. 2003;37:28–33.
    1. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: A multicentre, randomised controlled trial. Lancet. 2005;366:1704–10.
    1. Mc Callon SK, Knight CA, Valiulus JP, Cunningham MW, McCulloch JM, Farinas LP. Vacuum-assisted closure versus saline-moistened gauze in the healing of postoperative diabetic foot wounds. Ostomy Wound Manage. 2000;46:28–32. 34.
    1. Eginton MT, Brown KR, Seabrook GR, Towne JB, Cambria RA. A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds. Ann Vasc Surg. 2003;17:645–9.
    1. Blume PA, Walters J, Payne W, Ayala J, Lantis J, Blume PA, et al. Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: A multicenter randomized controlled trial. Diabetes Care. 2008;31:631–6.
    1. Armstrong DG, Lavery LA, Abu-Rumman P, Espensen EH, Vazquez JR, Nixon BP, et al. Outcomes of subatmospheric pressure dressing therapy on wounds of the diabetic foot. Ostomy Wound Manage. 2002;48:64–8.
    1. Page JC, Newswander B, Schwenke DC, Hansen M, Ferguson J. Retrospective analysis of negative pressure wound therapy in open foot wounds with significant soft tissue defects. Adv Skin Wound Care. 2004;17:354–64.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe